rs41310207

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000093.5(COL5A1):​c.2724G>A​(p.Pro908Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0316 in 1,613,304 control chromosomes in the GnomAD database, including 938 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P908P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.025 ( 67 hom., cov: 32)
Exomes 𝑓: 0.032 ( 871 hom. )

Consequence

COL5A1
NM_000093.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.41

Publications

6 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 9-134795105-G-A is Benign according to our data. Variant chr9-134795105-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136869.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.41 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0249 (3789/152282) while in subpopulation NFE AF = 0.0384 (2615/68014). AF 95% confidence interval is 0.0372. There are 67 homozygotes in GnomAd4. There are 1780 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3789 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.2724G>A p.Pro908Pro synonymous_variant Exon 33 of 66 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.2724G>A p.Pro908Pro synonymous_variant Exon 33 of 66 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.2724G>A p.Pro908Pro synonymous_variant Exon 33 of 65 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.2724G>A p.Pro908Pro synonymous_variant Exon 33 of 66 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.2724G>A p.Pro908Pro synonymous_variant Exon 33 of 66 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.0249
AC:
3793
AN:
152164
Hom.:
68
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00671
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0221
Gnomad ASJ
AF:
0.0421
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00934
Gnomad FIN
AF:
0.0271
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0385
Gnomad OTH
AF:
0.0316
GnomAD2 exomes
AF:
0.0259
AC:
6485
AN:
250822
AF XY:
0.0260
show subpopulations
Gnomad AFR exome
AF:
0.00626
Gnomad AMR exome
AF:
0.0144
Gnomad ASJ exome
AF:
0.0389
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0292
Gnomad NFE exome
AF:
0.0389
Gnomad OTH exome
AF:
0.0332
GnomAD4 exome
AF:
0.0323
AC:
47125
AN:
1461022
Hom.:
871
Cov.:
40
AF XY:
0.0317
AC XY:
23031
AN XY:
726862
show subpopulations
African (AFR)
AF:
0.00618
AC:
207
AN:
33478
American (AMR)
AF:
0.0159
AC:
710
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0395
AC:
1031
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00844
AC:
728
AN:
86256
European-Finnish (FIN)
AF:
0.0294
AC:
1569
AN:
53330
Middle Eastern (MID)
AF:
0.0293
AC:
169
AN:
5766
European-Non Finnish (NFE)
AF:
0.0368
AC:
40864
AN:
1111280
Other (OTH)
AF:
0.0306
AC:
1846
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
2327
4654
6980
9307
11634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1474
2948
4422
5896
7370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0249
AC:
3789
AN:
152282
Hom.:
67
Cov.:
32
AF XY:
0.0239
AC XY:
1780
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00669
AC:
278
AN:
41570
American (AMR)
AF:
0.0220
AC:
337
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0421
AC:
146
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00934
AC:
45
AN:
4816
European-Finnish (FIN)
AF:
0.0271
AC:
288
AN:
10608
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0384
AC:
2615
AN:
68014
Other (OTH)
AF:
0.0313
AC:
66
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
177
353
530
706
883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0339
Hom.:
120
Bravo
AF:
0.0237
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0389
EpiControl
AF:
0.0402

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 02, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Mar 14, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The COL5A1 c.2724G>A (p.Pro908Pro) variant involves the alteration of a conserved nucleotide causing a synonymous change, which 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may alter ESE binding. The variant of interest has been observed in the large, broad control population, ExAC, with an allele frequency of 3220/120556 (1/37, 68 homozygotes), which is approximately 21368 times the estimated maximal expected allele frequency for a pathogenic COL5A1 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Therefore, the variant of interest has been classified as Benign. -

Nov 30, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 06, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ehlers-Danlos syndrome Benign:1
Jul 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome type 7A Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.20
DANN
Benign
0.70
PhyloP100
-2.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41310207; hg19: chr9-137686951; COSMIC: COSV107479200; API